Parallel functional annotation of cancer-associated missense mutations in histone methyltransferases

Abstract Using exome sequencing for biomarker discovery and precision medicine requires connecting nucleotide-level variation with functional changes in encoded proteins. However, for functionally annotating the thousands of cancer-associated missense mutations, or variants of uncertain significance...

Full description

Bibliographic Details
Main Authors: Ashley J. Canning, Susan Viggiano, Martin E. Fernandez-Zapico, Michael S. Cosgrove
Format: Article
Language:English
Published: Nature Portfolio 2022-11-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-23229-2
_version_ 1811223636193837056
author Ashley J. Canning
Susan Viggiano
Martin E. Fernandez-Zapico
Michael S. Cosgrove
author_facet Ashley J. Canning
Susan Viggiano
Martin E. Fernandez-Zapico
Michael S. Cosgrove
author_sort Ashley J. Canning
collection DOAJ
description Abstract Using exome sequencing for biomarker discovery and precision medicine requires connecting nucleotide-level variation with functional changes in encoded proteins. However, for functionally annotating the thousands of cancer-associated missense mutations, or variants of uncertain significance (VUS), purifying variant proteins for biochemical and functional analysis is cost-prohibitive and inefficient. We describe parallel functional annotation (PFA) of large numbers of VUS using small cultures and crude extracts in 96-well plates. Using members of a histone methyltransferase family, we demonstrate high-throughput structural and functional annotation of cancer-associated mutations. By combining functional annotation of paralogs, we discovered two phylogenetic and clustering parameters that improve the accuracy of sequence-based functional predictions to over 90%. Our results demonstrate the value of PFA for defining oncogenic/tumor suppressor functions of histone methyltransferases as well as enhancing the accuracy of sequence-based algorithms in predicting the effects of cancer-associated mutations.
first_indexed 2024-04-12T08:36:11Z
format Article
id doaj.art-4e8bfe39794b477585dcf9d054f04673
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-04-12T08:36:11Z
publishDate 2022-11-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-4e8bfe39794b477585dcf9d054f046732022-12-22T03:40:00ZengNature PortfolioScientific Reports2045-23222022-11-0112111310.1038/s41598-022-23229-2Parallel functional annotation of cancer-associated missense mutations in histone methyltransferasesAshley J. Canning0Susan Viggiano1Martin E. Fernandez-Zapico2Michael S. Cosgrove3Department of Biochemistry and Molecular Biology, State University of New York (SUNY) Upstate Medical UniversityDepartment of Biochemistry and Molecular Biology, State University of New York (SUNY) Upstate Medical UniversitySchulze Center for Novel Therapeutics, Division of Oncology Research, Mayo ClinicDepartment of Biochemistry and Molecular Biology, State University of New York (SUNY) Upstate Medical UniversityAbstract Using exome sequencing for biomarker discovery and precision medicine requires connecting nucleotide-level variation with functional changes in encoded proteins. However, for functionally annotating the thousands of cancer-associated missense mutations, or variants of uncertain significance (VUS), purifying variant proteins for biochemical and functional analysis is cost-prohibitive and inefficient. We describe parallel functional annotation (PFA) of large numbers of VUS using small cultures and crude extracts in 96-well plates. Using members of a histone methyltransferase family, we demonstrate high-throughput structural and functional annotation of cancer-associated mutations. By combining functional annotation of paralogs, we discovered two phylogenetic and clustering parameters that improve the accuracy of sequence-based functional predictions to over 90%. Our results demonstrate the value of PFA for defining oncogenic/tumor suppressor functions of histone methyltransferases as well as enhancing the accuracy of sequence-based algorithms in predicting the effects of cancer-associated mutations.https://doi.org/10.1038/s41598-022-23229-2
spellingShingle Ashley J. Canning
Susan Viggiano
Martin E. Fernandez-Zapico
Michael S. Cosgrove
Parallel functional annotation of cancer-associated missense mutations in histone methyltransferases
Scientific Reports
title Parallel functional annotation of cancer-associated missense mutations in histone methyltransferases
title_full Parallel functional annotation of cancer-associated missense mutations in histone methyltransferases
title_fullStr Parallel functional annotation of cancer-associated missense mutations in histone methyltransferases
title_full_unstemmed Parallel functional annotation of cancer-associated missense mutations in histone methyltransferases
title_short Parallel functional annotation of cancer-associated missense mutations in histone methyltransferases
title_sort parallel functional annotation of cancer associated missense mutations in histone methyltransferases
url https://doi.org/10.1038/s41598-022-23229-2
work_keys_str_mv AT ashleyjcanning parallelfunctionalannotationofcancerassociatedmissensemutationsinhistonemethyltransferases
AT susanviggiano parallelfunctionalannotationofcancerassociatedmissensemutationsinhistonemethyltransferases
AT martinefernandezzapico parallelfunctionalannotationofcancerassociatedmissensemutationsinhistonemethyltransferases
AT michaelscosgrove parallelfunctionalannotationofcancerassociatedmissensemutationsinhistonemethyltransferases